Brinavess 500 mg, Konzentrat zur Herstellung einer Infusionslösung
7680613040032
CH-61304
Konzentrat
Associated product:
BRINAVESS conc perf 500 mg/25ml flac 25 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
vernakalanti hydrochloridum
|
500.0 MG | Substance | WIZUS |
|
vernakalantum
|
452.5 MG | Substance | Wirkstoff (Principe actif) |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
78.75 MG | Substance | HBESI |
Authorization holder
Curatis AG
4410 Liestal
Authorization information
- Swissmedic authorization number
- 61304
- Drug name
- Brinavess, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- C01BG11
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 16/03/2011
- Authorization expiration date
- 31/12/9999
- IT Number
- 02.02.0.
- Domain
- Human medicine
Package details
- Description (FR)
- BRINAVESS conc perf 500 mg/25ml flac 25 ml
- Description (DE)
- BRINAVESS Inf Konz 500 mg/25ml Durchstf 25 ml
- Market launch
- 16/03/2011
- Market withdrawal
- 31/05/2026
- Narcotic (BTM)
- No